The United States is falling dangerously behind in medical research as other companies make
tremendous progress. Farron, this story about the Cub, about Cuba drugs, Cuban drugs that really are
making a difference in Alzheimer's disease. Now we compare that to what happened with GenTech
and what happened with Biogen, GenTech and Biogen lied to the American public for a decade.
They said, we have this great Alzheimer's drug. The, even, even the clinicals were phonied up.
But we know the Cubans, the Cuban drug really does work. I mean, there's,
the clinicals are, are first of all, they're honest, nothing phonied up and it's working.
Right. Give me your take on it.
The, Cuba is now in phase four. Yes.
Of their drug trials for this Alzheimer's and Parkinson's drug, because it's showing that,
hey, it's stopping, it is stopping brain deterioration and helping people actually
improve their cognitive functions. Yeah.
That is amazing. They're almost, I mean, I don't want to give too much hope here, but it seems like
they're almost reversing these, these conditions. If you read the, if you read the articles, you,
you, you certainly looks like that. Yeah. And then we, as you said,
contrast this to the US, which by the way, both of these stories came out within about 48 hours
of each other. Mm-hmm.
And nobody connected them. No.
But the US, 20 years, our drug companies that we are funding through the National Institute
of Health using taxpayer dollars. Mm-hmm.
It's so, the phoning up was so bad, they weren't just lying about the results, they were
Photoshopping their own images of people's brains. Yes.
To show, oh, look, it got better. Yes.
And then they finally looked and said, wait a minute, you just took a picture of a healthy brain
and cut out that part and glued it on top. Okay. There's a reason for all this. Okay. And
there, we have a 99% failure rate with American, 99%, with American companies that are saying,
we're solving this problem. First of all, they started off with a lie. That, that's where this
all begins. Yeah.
The big lie started off with phonied up research that was coming that said, look, if we can deal
with the amyloid problem and the plaque problem, if we can reduce the amyloid problem in the brain
and the plaque problem in the brain, we're gonna cure it. They found out, no, that's not even,
it's not even accurate. They were said, we, we have a drug because we have reduced plaques and
we have reduced the amyloid problem, but it had nothing to do in the long run with Alzheimer's.
Right. So they developed these drugs that attacked these issues that were not the issues.
Yeah. And honest to God,
the difference here, because it's not just Cuba, who also, by the way, has a lung cancer vaccine
that we're in the US not allowed to take. So they've got this, they've got the Parkinson's
treatment, the Alzheimer's. South Korea has become a leader in medical develop. China,
China has taken over. Mm-hmm.
It's because we are profit driven here in the United States. We let big profits,
so instead of tackling the real diseases, what are our drug companies doing? We'll look at the ads on
TV. Are you moving your leg a little too much while you sleep? Here's $500 a month for this
drug. It'll stop your leg movement. Are your eyes a little too scratchy every now and then?
Mm-hmm. Those are the problems
we're tackling while the rest of the world. It's low, it's called low, corporate low
hanging fruit. Yeah.
Okay. And, and here's, here's one big difference. When, the best article that I saw that analyzed
this, they said, look, there's a research gap in America that there's not in some of these other
companies, in other countries like Cuba, because the, the, the research is driven by government.
Government is hands on, on that research. Academic institutions are hands on with that research.
And, and then they tie up the idea that if we compare our kind of what, what you, what
you would call is the stem system of education, where they, they, they found out now we don't,
we don't, we don't, teach calculus. We don't teach the kind of advanced biology that people need to
have in school. We've cut back all of our hard, hard sciences for the most part in public schools.
And these, the, the list of comparisons between why we're, we are where we are in the United
States with corporate driven research versus government slash education driven
research is a big difference. Isn't it? Well, and, and these big pharmaceutical
companies go out there, they headhunt these individuals, the, the smart folks, the scientists,
and they say, hey, listen, you've got a very promising career ahead of you.
How would you like to come make $300,000 a year, fresh outta school with your PhD? Uh,
but instead of working on cancer, how about you work on this, you know, a new antacid for us.
Yeah. We, we, we know there's a lot of heartburn
medications, but you work on this one, we'll pay you a lot of money, you're gonna be fine.
But, and the end result, we're seeing more and more. It's kinda like the chickens have come
home to roost. Okay. And the end result is we're seeing a disaster where it comes to performance of
drug after drug, medical device after medical device. And it needs to be rethought. Farron,
thanks for joining me. Okay. Thank you.
That's for this week. But all these segments are gonna be available this coming week,
right here on this channel. And you can follow us on Twitter, you can follow us @AmericasLawyer.
I'm Mike Papantonio and this has been America's Lawyer where every week we try to tell you the
stories that corporate media won't tell you because their advertisers won't allow for it
and sometimes their political connections won't allow for it. So we try to avoid all that. We call
balls and strikes here. There is no side. There is no Democrat side. There's no Republican side.
It is balls and strikes. It's not for everybody, but we hope you enjoy it. We'll see you next time.